Clinical trials

Filters
Clear filters
1,718 trials
TrialSponsorPhaseStatusPrimary completion
Efficacy and Safety of Rexlemestrocel-L Combined With HA* in Participants With Moderate to Severe Chronic Low Back PainNCT06325566MESOPhase 3Active not recruiting2027-07Estimated
RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic SclerosisNCT06328777Cabaletta BioPhase 2, Phase 3Recruiting2029-07Estimated
A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary FibrosisNCT06329401AVLNPhase 2Active not recruiting2027-06Estimated
A Phase 3 Study of UGN-103 for Treatment of Patients With Low-grade Intermediate-risk Non-muscle Invasive Bladder CancerNCT06331299URGNPhase 3Completed2025-09-11Actual
Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 DiabetesNCT06334133vTv TherapeuticsPhase 3Active not recruiting2027-04Estimated
A Study to Evaluate Efficacy and Safety of Intravenous Sabirnetug in Participants With Early Alzheimer's Disease (ALTITUDE-AD)NCT06335173Acumen PharmaceuticalsPhase 2Active not recruiting2026-10-29Actual
A Phase 2b Study to Evaluate Rezpegaldesleukin (Rezpeg) in the Treatment of Severe to Very Severe Alopecia Areata in Adult Patients (Rezolve AA)NCT06340360NKTRPhase 2Completed2025-11-26Actual
ALG-055009 in Non-cirrhotic Adults With MASH (HERALD)NCT06342947Aligos TherapeuticsPhase 2Completed2024-08-19Actual
A Study to Assess Naporafenib (ERAS-254) Administered With Trametinib in Patients With NRAS-mutant Melanoma (SEACRAFT-2)NCT06346067ERASPhase 3Active not recruiting2028-04Estimated
Study of Plozasiran (ARO-APOC3) in Adults With Severe HypertriglyceridemiaNCT06347003Arrowhead PharmaceuticalsPhase 3Completed2026-06-12Actual
Study of Plozasiran in Adults With Severe HypertriglyceridemiaNCT06347016Arrowhead PharmaceuticalsPhase 3Completed2026-06-17Actual
Phase 3 Study of Plozasiran in Adults With HypertriglyceridemiaNCT06347133Arrowhead PharmaceuticalsPhase 3Completed2026-06-01Actual
A Study of EDG-7500 in Adults With Hypertrophic Cardiomyopathy (CIRRUS-HCM)NCT06347159EWTXPhase 2Active not recruiting2027-12Estimated
Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder (PALISADE-3)NCT06358651VTGNPhase 3Completed2025-10-31Actual
A Study to Evaluate the Safety and Effectiveness of ALKS 2680 in Subjects With Narcolepsy Type 1 (ALKS 2680-201)NCT06358950Alkermes, Inc.Phase 2Completed2025-06-19Actual
Ropidoxuridine as a Radiosensitizer in Newly Diagnosed IDH-Wildtype Glioblastoma With Unmethylated MGMT PromoterNCT06359379Shuttle Pharmaceuticals, Inc.Phase 2Terminated2025-12-01Actual
Progressing TAAR-1, Dopamine, and Norepinephrine in Depression Using SolriamfetolNCT06360419AXSMPhase 3Completed2024-12-31Actual
A Study of Barzolvolimab in Patients With Prurigo NodularisNCT06366750Celldex TherapeuticsPhase 2Active not recruiting2026-03-17Actual
A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast CancerNCT06369285PBYIPhase 2Recruiting2027-12-30Estimated
A Study of Auxora in Patients With AKI and Injurious Lung "Crosstalk"NCT06374797CALCPhase 2Terminated2026-04-06Actual
Study Evaluating the Safety and Efficacy of RAP-219 in Adult Participants With Refractory Focal EpilepsyNCT06377930RAPPPhase 2Completed2025-09-26Actual
A Phase 2 Study of ZL-1102 in Patients With Chronic Plaque PsoriasisNCT06380907Zai Lab (Hong Kong), Ltd.Phase 2Terminated2025-12-16Actual
KYSA-7: A Study of Anti-CD19 CAR T-Cell Therapy, in Subjects With Refractory Primary and Secondary Progressive Multiple SclerosisNCT06384976Kyverna TherapeuticsPhase 2Active not recruiting2027-04Estimated
Dusquetide for the Treatment of Behcet's DiseaseNCT06386744SoligenixPhase 2Completed2025-05-23Actual
Namodenoson Treatment of Advanced Pancreatic CancerNCT06387342Can-Fite BioPharmaPhase 2Recruiting2026-07-15Estimated
A Phase 2/3 Study to Evaluate the Efficacy and Safety of Tinlarebant in Subjects With Stargardt DiseaseNCT06388083BLTEPhase 2, Phase 3Active not recruiting2028-02Estimated
A Phase 3 Study Of OCU400 Gene Therapy for the Treatment Of Retinitis PigmentosaNCT06388200OcugenPhase 3Active not recruiting2027-02-12Estimated
A Clinical Trial to Assess the Efficacy and Safety of Subjects With Dry Eye DiseaseNCT06389214ALDXPhase 3Completed2024-06-11Actual
A Pivotal Study of APG-2575 (Lisaftoclax) Combined With Azacitidine in the Treatment of Acute Myeloid LeukemiaNCT06389292Ascentage Pharma Group Inc.Phase 3Recruiting2028-05-25Estimated
EF-39 PANOVA-4: Study of Tumor Treating Fields Concomitant With Atezolizumab, Gemcitabine and Nab-Paclitaxel as First-LineTreatment for Metastatic Pancreatic Ductal AdenocarcinomaNCT06390059NVCRPhase 2Completed2025-11-18Actual

Primary completion marks the end of data collection for the main study measures, not a results publication date.